Regeneron’s Deal With Roche to Make Covid Antibody ‘Should Add Credibility to This Program’

This post was originally published on this site

Regeneron Pharmaceuticals announced a deal with rival drugmaker Roche Holding to manufacture Regeneron’s experimental Covid-19 antibody cocktail, a deal that could triple the amount of doses available worldwide. If the antibody cocktail, which …

Click here to read full article